Literature DB >> 2417643

The control of complement activation by the blood cells in paroxysmal nocturnal hemoglobinuria.

W F Rosse.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1986        PMID： 2417643

Source DB:  PubMed          Journal:  Blood        ISSN： 0006-4971            Impact factor:   22.113


× No keyword cloud information.
  6 in total

1.  The C8-binding protein of human erythrocytes: interaction with the components of the complement-attack phase.

Authors:  S Schönermark; S Filsinger; B Berger; G M Hänsch
Journal:  Immunology       Date:  1988-04       Impact factor: 7.397

2.  Decay-accelerating factor is expressed on vascular smooth muscle cells in human atherosclerotic lesions.

Authors:  P S Seifert; G K Hansson
Journal:  J Clin Invest       Date:  1989-08       Impact factor: 14.808

3.  Altered expression of gangliosides in erythrocytes of paroxysmal nocturnal hemoglobinuria.

Authors:  H Nakakuma; T Kawaguchi; K Horikawa; M Hidaka; Y Yonemura; M Kawakita; T Kagimoto; M Iwamori; Y Nagai; K Takatsuki
Journal:  J Clin Invest       Date:  1990-05       Impact factor: 14.808

Review 4.  Infectious diseases associated with complement deficiencies.

Authors:  J E Figueroa; P Densen
Journal:  Clin Microbiol Rev       Date:  1991-07       Impact factor: 26.132

5.  Hemolysis of human erythrocytes is a new bioactivity of gangliosides.

Authors:  K Horikawa; H Nakakuma; S Nagakura; M Kawakita; T Kagimoto; M Iwamori; Y Nagai; T Abe; K Takatsuki
Journal:  J Exp Med       Date:  1991-12-01       Impact factor: 14.307

6.  Identification of human erythrocyte blood group antigens on decay-accelerating factor (DAF) and an erythrocyte phenotype negative for DAF.

Authors:  M J Telen; S E Hall; A M Green; J J Moulds; W F Rosse
Journal:  J Exp Med       Date:  1988-06-01       Impact factor: 14.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.